New hope for hard-to-heal leg ulcers: cell therapy enters final testing
NCT ID NCT06489028
First seen Nov 01, 2025 · Last updated May 08, 2026 · Updated 26 times
Summary
This phase 3 trial tests a topical cell therapy called Allo-APZ2-CVU for chronic venous leg ulcers that haven't healed with standard care. About 250 adults with ulcers between 1 and 25 cm² are enrolled. The goal is to see if the treatment leads to complete wound closure lasting at least two weeks, compared to a placebo.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VENOUS LEG ULCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
RHEACELL Clinical Trial Site
Hialeah, Florida, 33012, United States
-
RHEACELL Clinical Trial Site
Miami, Florida, 33136, United States
-
RHEACELL Clinical Trial Site
Boston, Massachusetts, 02114, United States
-
RHEACELL Clinical Trial Site
Minneapolis, Minnesota, 55455, United States
-
RHEACELL Clinical Trial Site
Multiple Locations, Austria
-
RHEACELL Clinical Trial Site
Multiple Locations, Czechia
-
RHEACELL Clinical Trial Site
Multiple Locations, France
-
RHEACELL Clinical Trial Site
Several Locations, Germany
-
RHEACELL Clinical Trial Site
Multiple Locations, Hungary
-
RHEACELL Clinical Trial Site
Multiple Locations, Italy
-
RHEACELL Clinical Trial Site
Multiple Locations, Netherlands
-
RHEACELL Clinical Trial Site
Multiple Locations, Poland
-
RHEACELL Clinical Trial Site
Multiple Locations, Slovakia
-
RHEACELL Clinical Trial Site
Multiple Locations, Sweden
-
RHEACELL Clinical Trial Site
Multiple Locations, United Kingdom
Conditions
Explore the condition pages connected to this study.